


Searching News Database: Oxford BioMedica
HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Additional items found! 2
Members Archive contains
2 additional stories matching:
Oxford BioMedica
(Password required)
Oxford BioMedica
(Password required)
